Arnica Extract is a phytopharmaceutical preparation derived from plant source material through extraction or expression processes that concentrate pharmacologically active secondary metabolites. The chemical fingerprint of Arnica Extract varies with botanical species, chemotype, geographic origin, and harvest season, necessitating validated HPLC-based analytical methods capable of identity confirmation and quantification of characteristic marker compounds.
Health-based exposure limits for Arnica Extract require formal periodic review as new toxicological evidence, clinical safety data, or regulatory agency assessments become available. Pharmaceutical manufacturers are expected to maintain a defined review cycle—typically every 3–5 years or triggered by significant new findings—and to update OEL, PDE,
